Josepmaria Argemi

20PUBLICATIONS
127CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Epigenetics (incl. genome methylation and epigenomics)Health counselling
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Oct 21, 2025
Pan-microbial serological repertoire as a biomarker of immunotherapy response in hepatocellular carcinoma.

Shay Behrens, Whitney Leet Do, Limin Wang

|Sep 13, 2025
Immune-Checkpoint Inhibitors for Biliary Tract Cancer: Who Benefits and What Is Next?

Lucía Ceniceros, Manuel de La Torre, Ana Landa Magdalena

|Jun 26, 2025
Multi-Cohort Exploration of Repetitive Element Transcription and DNA Methylation in Human Steatotic Liver Disease.

Neil A Youngson, Aikaterini Tourna, Timothy Chalmers

|Mar 13, 2025
Hepatic stellate cells control liver zonation, size and functions via R-spondin 3.

Atsushi Sugimoto, Yoshinobu Saito, Guanxiong Wang

|Mar 11, 2025
MORPHEUS-Liver provides a way forward in expanding the immunotherapy options for hepatocellular carcinoma.

Bruno Sangro, Josepmaria Argemí

Pageof 4